1. ADAM12 promotes the resistance of lung adenocarcinoma cells to EGFR-TKI and regulates the immune microenvironment by activating PI3K/Akt/mTOR and RAS signaling pathways
   Keyu Li et al, 2023, International Immunopharmacology CrossRef
2. New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials
   Peng He et al, 2023, Environmental Research CrossRef
3. Roles of follistatin-like protein 3 in human non-tumor pathophysiologies and cancers
   Shifeng Tian et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
4. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway
   Jinming Xu et al, 2023, Journal of Translational Medicine CrossRef
5. Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment
   Eleonora Malavasi et al, 2024, Cancers CrossRef
6. ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer
   Runchang Wang et al, 2022, Clinical and Translational Oncology CrossRef
7. COL8A1 is a prognostic-related biomarker and correlated with immune infiltration in gastric cancer
   Hao Feng et al, 2023, Clinical Surgical Oncology CrossRef
8. ADAM12 Silencing Mediated by FOXC2 Represses Meningioma Progression Through Inactivating the JAK1/STAT3/VEGFA Pathway
   Huaming Zhang et al, 2024, Biochemical Genetics CrossRef
9. Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study
   Hanaa M. Ibrahim et al, 2023, Applied Immunohistochemistry & Molecular Morphology CrossRef
10. Single‐cell and spatial transcriptomics reveal POSTN+ cancer‐associated fibroblasts correlated with immune suppression and tumour progression in non‐small cell lung cancer
    Chao Chen et al, 2023, Clinical and Translational Medicine CrossRef
11. LUM as a novel prognostic marker and its correlation with immune infiltration in gastric cancer: a study based on immunohistochemical analysis and bioinformatics
    Wu Xu et al, 2023, BMC Gastroenterology CrossRef
12. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
    Nasim Ebrahimi et al, 2024, Cancer and Metastasis Reviews CrossRef
13. Alternatively Spliced Isoforms of MUC4 and ADAM12 as Biomarkers for Colorectal Cancer Metastasis
    Saleh Althenayyan et al, 2023, Journal of Personalized Medicine CrossRef
14. Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth
    Opeyemi Olotu et al, 2024, Cell Reports CrossRef
15. A new strategy to identify ADAM12 and PDGFRB as a novel prognostic biomarker for matrine regulates gastric cancer via high throughput chip mining and computational verification
    Yifei Gao et al, 2023, Computers in Biology and Medicine CrossRef
16. Serum ADAM metallopeptidase domain 12 as a promising diagnostic biomarker for breast and liver cancer
    Hanchu Wang et al, 2022, Clinical and Translational Oncology CrossRef